Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results.

Qureshi AI, Feldmann E, Gomez CR, Johnston SC, Kasner SE, Quick DC, Rasmussen PA, Suri MF, Taylor RA, Zaidat OO.

J Neuroimaging. 2009 Oct;19 Suppl 1:1S-10S. doi: 10.1111/j.1552-6569.2009.00414.x.

PMID:
19807850
2.

Intracranial atherosclerotic disease: an update.

Qureshi AI, Feldmann E, Gomez CR, Johnston SC, Kasner SE, Quick DC, Rasmussen PA, Suri MF, Taylor RA, Zaidat OO.

Ann Neurol. 2009 Dec;66(6):730-8. doi: 10.1002/ana.21768. Review.

PMID:
20035502
3.

Medical treatment of patients with intracranial atherosclerotic disease.

Gomez CR, Qureshi AI.

J Neuroimaging. 2009 Oct;19 Suppl 1:25S-9S. doi: 10.1111/j.1552-6569.2009.00419.x.

PMID:
19807855
4.

Epidemiology, diagnosis and management of intracranial atherosclerotic disease.

Jeng JS, Tang SC, Liu HM.

Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1423-32. doi: 10.1586/erc.10.129. Review.

PMID:
20936929
5.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
6.

Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.

Hanley D, Gorelick PB, Elliott WJ, Broder MS, Saver JL, Kidwell CS, Fagan SC, Wilson A, Lennihan L, Schwer WA, Rubenstein LZ, Crowell RM, Haines SJ, Lopez CC, Zorowitz R, Dubois RW.

J Stroke Cerebrovasc Dis. 2004 Sep-Oct;13(5):196-207.

PMID:
17903976
7.

Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.

Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators.

Circulation. 2006 Jan 31;113(4):555-63. Epub 2006 Jan 23.

8.

Intracranial atherosclerotic disease: epidemiology, imaging and treatment.

McTaggart RA, Jayaraman MV, Haas RA, Feldmann E.

Med Health R I. 2009 Dec;92(12):412-4. Review.

PMID:
20066829
9.

CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.

Hoh BL, Gong Y, McDonough CW, Waters MF, Royster AJ, Sheehan TO, Burkley B, Langaee TY, Mocco J, Zuckerman SL, Mummareddy N, Stephens ML 2nd, Ingram C, Shaffer CM, Denny JC, Brilliant MH, Kitchner TE, Linneman JG, Roden DM, Johnson JA.

J Neurosurg. 2016 Jun;124(6):1746-51. doi: 10.3171/2015.6.JNS15795. Epub 2015 Nov 20.

10.

Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association.

Moore WS, Barnett HJ, Beebe HG, Bernstein EF, Brener BJ, Brott T, Caplan LR, Day A, Goldstone J, Hobson RW 2nd, et al.

Circulation. 1995 Jan 15;91(2):566-79. Review.

11.

Management of patients with symptomatic intracranial atherosclerosis.

Leung TW, Kwon SU, Wong KS.

Int J Stroke. 2006 Feb;1(1):20-5. doi: 10.1111/j.1747-4949.2005.00014.x. Review.

PMID:
18706064
12.

High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.

Kozak O, Tariq N, Suri MF, Taylor RA, Qureshi AI.

Neurosurgery. 2011 Aug;69(2):334-42; discussion 342-3. doi: 10.1227/NEU.0b013e31821789ad.

PMID:
21430591
13.

Antiplatelet agents and randomized trials.

Diener HC.

Rev Neurol Dis. 2007 Fall;4(4):177-83. Review.

PMID:
18195669
14.

How effective is endovascular intracranial revascularization in stroke prevention? Results from Borgess Medical Center Intracranial Revascularization Registry.

Al-Ali F, Cree T, Duan L, Hall S, Jefferson A, Louis S, Major K, Smoker S, Walker S.

AJNR Am J Neuroradiol. 2011 Aug;32(7):1227-31. doi: 10.3174/ajnr.A2670. Epub 2011 Jul 21.

15.
16.

Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis.

Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N.

Neurology. 2007 Feb 6;68(6):420-6.

PMID:
17283316
17.

Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.

Dumont TM, Sonig A, Mokin M, Eller JL, Sorkin GC, Snyder KV, Nelson Hopkins L, Levy EI, Siddiqui AH.

J Neurosurg. 2016 Oct;125(4):964-971. Epub 2016 Jan 8.

PMID:
26745485
18.

Natural history of symptomatic intracranial arterial stenosis.

Kasner SE.

J Neuroimaging. 2009 Oct;19 Suppl 1:20S-1S. doi: 10.1111/j.1552-6569.2009.00417.x.

PMID:
19807853
19.

Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis.

Qureshi AI, Hussein HM, El-Gengaihy A, Abdelmoula M, K Suri MF.

Neurosurgery. 2008 May;62(5):1053-60; discussion 1060-2. doi: 10.1227/01.neu.0000325867.06764.3a.

PMID:
18580803
20.

Supplemental Content

Support Center